Hypertension Diagnostics, Inc.
HDII · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $2 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $5 |
| Enterprise Value | $2 | $3 | $3 | $5 |
| Revenue | $0 | $0 | $0 | $4 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | – | – | 25.2% |
| EBITDA | $0 | $0 | $4 | $0 |
| % Margin | – | – | – | 1.9% |
| Net Income | -$0 | -$0 | $3 | -$0 |
| % Margin | – | – | – | -3.3% |
| EPS Diluted | -0 | -0 | 0.024 | -0.001 |
| % Growth | -300% | -100.4% | 2,777.8% | – |
| Operating Cash Flow | -$1 | -$0 | $3 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$0 | $3 | -$0 |